Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
Eur J Prev Cardiol ; 21(7): 823-8, 2014 Jul.
Article in English | MEDLINE | ID: mdl-23197402

ABSTRACT

BACKGROUND: Aromatherapy is widely used around the world for stress relief. Whether exposure to essential oil increases the risk of cardiovascular events is still unknown. The purpose of this study was to investigate the effect of essential oil on heart rate and blood pressure among solus por aqua (spa) workers. METHODS: We recruited 100 healthy workers from various spa centres in Taipei, Taiwan. Between July and August of 2010, three repeated measurements - resting heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure (DBP) - were taken of each spa worker in our study room. Participants were exposed to essential oil vapour generated from an ultrasonic atomizer in the study room for two consecutive hours. The total volatile organic compound (VOC) level in the study room was measured during the study period. We used a linear mixed-effect model to determine the association between the total VOC level and the participants' HR, SBP, and DBP. RESULTS: For the times from 15 to 60 min after start of exposure, we found that the VOC level was significantly associated with reduced 15-min mean BP and HR. After exposure for more than 1 hour, from 75 to 120 min after start of exposure, we found that the VOC levels were associated with increased 15-min mean BP and HR. CONCLUSIONS: Exposure to essential oil for 1 hour was found to be an effective method of relaxation, as indicated by decreases in the HR and BP. Prolonged exposure for longer than 1 hour to essential oils may be harmful to cardiovascular health among spa workers.


Subject(s)
Aromatherapy/adverse effects , Blood Pressure/drug effects , Heart Rate/drug effects , Oils, Volatile/adverse effects , Adult , Aromatherapy/methods , Balneology , Blood Pressure Determination , Blood Pressure Monitoring, Ambulatory , Female , Humans , Male , Taiwan , Workforce , Young Adult
2.
PLoS One ; 8(12): e82081, 2013.
Article in English | MEDLINE | ID: mdl-24312629

ABSTRACT

BACKGROUND: Feline infectious peritonitis (FIP) is a lethal immune-mediated disease caused by feline coronavirus (FCoV). Currently, no therapy with proven efficacy is available. In searching for agents that may prove clinically effective against FCoV infection, five analogous overlapping peptides were designed and synthesized based on the putative heptad repeat 2 (HR2) sequence of the spike protein of FCoV, and the antiviral efficacy was evaluated. METHODS: Plaque reduction assay and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cytotoxicity assay were performed in this study. Peptides were selected using a plaque reduction assay to inhibit Feline coronavirus infection. RESULTS: The results demonstrated that peptide (FP5) at concentrations below 20 µM inhibited viral replication by up to 97%. The peptide (FP5) exhibiting the most effective antiviral effect was further combined with a known anti-viral agent, human interferon-α (IFN-α), and a significant synergistic antiviral effect was observed. CONCLUSION: Our data suggest that the synthetic peptide FP5 could serve as a valuable addition to the current FIP prevention methods.


Subject(s)
Antiviral Agents/pharmacology , Coronavirus Infections/drug therapy , Coronavirus, Feline/drug effects , Coronavirus, Feline/physiology , Peptide Fragments/pharmacology , Spike Glycoprotein, Coronavirus/chemistry , Amino Acid Sequence , Animals , Antiviral Agents/chemistry , Antiviral Agents/therapeutic use , Cats , Cell Line , Drug Evaluation, Preclinical , Drug Synergism , Humans , Interferon-alpha/pharmacology , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/therapeutic use , Protein Structure, Tertiary , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL